Log in to save to my catalogue

Brain-disabling treatments in psychiatry : drugs, electroshock, and the role of the FDA / Peter R. B...

Brain-disabling treatments in psychiatry : drugs, elect...

Brain-disabling treatments in psychiatry : drugs, electroshock, and the role of the FDA / Peter R. B...

https://devfeature-collection.sl.nsw.gov.au/record/74VM4dB3zVWy

Brain-disabling treatments in psychiatry : drugs, electroshock, and the role of the FDA / Peter R. Breggin.

About this item

Full title

Brain-disabling treatments in psychiatry : drugs, electroshock, and the role of the FDA / Peter R. Breggin.

Publisher

New York : Springer Pub. Co., c1997.

Call Numbers

N616.891 27

Record Identifier

74VM4dB3zVWy

MMS ID

991001335009702626

Language

English

Formats

Physical Description

Physical content

xii, 306 p. ; 24 cm.

Contents

1. The Brain-Disabling Principles of Psychiatric Treatment -- 2. Deactivation Syndrome (Chemical Lobotomy) Caused by Neuroleptics -- 3. Neuroleptic-Induced Anguish, Including Agitation, Despair, and Depression -- 4. Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Tardive Dystonia, and Tardive Ak...

Publication information

Publisher

New York : Springer Pub. Co., c1997.

Place of Publication

New York (State)

Date Published

c1997.

More information

Alternative Titles

Full title

Brain-disabling treatments in psychiatry : drugs, electroshock, and the role of the FDA / Peter R. Breggin.

Authors, Artists and Contributors
Notes

General note

Includes bibliographical references (p. 234-293) and index.

Contextual Information

Date Copyright

c1997.

Identifiers

Primary Identifiers

Call Numbers

N616.891 27

Record Identifier

74VM4dB3zVWy

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/74VM4dB3zVWy

Other Identifiers

ISBN

0826194907

9780826194909

DDC

616.891

MMS ID

991001335009702626

How to access this item

1 of 0Request as a Library member